Sabadell Asset Management’s Moderna MRNA Stock Holding History

Sabadell Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$172K	Hold	1,416	–	–	0.04%	96
2023 Q1	$219K	Hold	1,416	–	–	0.05%	100
2022 Q4	$264K	Hold	1,416	–	–	0.05%	109
2022 Q3	$178K	Hold	1,416	–	–	0.04%	108
2022 Q2	$226K	Hold	1,416	–	–	0.05%	137
2022 Q1	$225K	Hold	1,416	–	–	0.04%	155
2021 Q4	$298K	Hold	1,416	–	–	0.05%	145
2021 Q3	$545K	Hold	1,416	–	–	0.09%	139
2021 Q2	$333K	Buy	+1,416	New	+$253K	0.06%	146

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Sabadell Asset Management's MRNA Position: Q2 2023 in Review

Sabadell Asset Management held its Moderna (MRNA) position steady in Q2 2023 at 1,416 shares worth $172K. The position accounts for 0.04% of the portfolio, ranked #96.

Sabadell Asset Management first reported a position in MRNA in Q2 2021 and has held it in 9 quarters since. The position peaked at $545K in Q3 2021. 967 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

Sabadell Asset Management held 1,416 shares of Moderna worth $172K as of Q2 2023.
Sabadell Asset Management left its Moderna share count unchanged in Q2 2023.
Moderna made up 0.04% of Sabadell Asset Management's portfolio in Q2 2023, its #96 holding.
Sabadell Asset Management first reported a position in Moderna in Q2 2021 and has held it in 9 quarters since.
Sabadell Asset Management's Moderna position peaked at $545K in Q3 2021.
967 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on Sabadell Asset Management's 13F filing for Q2 2023, filed 23 Jan 2024.